Hyperion DeFi (NASDAQ:HYPD) Trading 3.9% Higher – Here’s Why

Hyperion DeFi, Inc. (NASDAQ:HYPD)’s share price shot up 3.9% during mid-day trading on Monday . The company traded as high as $3.21 and last traded at $3.18. 275,886 shares changed hands during trading, a decline of 65% from the average daily volume of 790,228 shares. The stock had previously closed at $3.06.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HYPD shares. Chardan Capital decreased their target price on shares of Hyperion DeFi from $8.25 to $7.30 and set a “buy” rating on the stock in a report on Monday, June 8th. Cantor Fitzgerald upgraded shares of Hyperion DeFi to a “strong-buy” rating in a research report on Thursday, April 9th. Zacks Research cut shares of Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research note on Monday, March 30th. Finally, Weiss Ratings raised shares of Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $5.65.

Hyperion DeFi Trading Up 3.9%

The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $48.20 million, a P/E ratio of -0.32 and a beta of 2.48. The firm has a 50-day moving average of $3.56 and a two-hundred day moving average of $3.51.

Hyperion DeFi (NASDAQ:HYPD) last released its earnings results on Thursday, March 26th. The company reported ($7.76) earnings per share (EPS) for the quarter. The business had revenue of $0.50 million during the quarter. On average, analysts anticipate that Hyperion DeFi, Inc. will post 1.71 EPS for the current year.

Insider Activity at Hyperion DeFi

In related news, insider Hyunsu Jung purchased 7,000 shares of Hyperion DeFi stock in a transaction dated Monday, June 1st. The shares were bought at an average cost of $3.70 per share, for a total transaction of $25,900.00. Following the purchase, the insider owned 1,384,676 shares in the company, valued at approximately $5,123,301.20. This trade represents a 0.51% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 7.50% of the company’s stock.

Hedge Funds Weigh In On Hyperion DeFi

A number of institutional investors have recently added to or reduced their stakes in HYPD. Redwood Wealth Management Group LLC boosted its position in Hyperion DeFi by 2.1% in the first quarter. Redwood Wealth Management Group LLC now owns 183,273 shares of the company’s stock valued at $632,000 after buying an additional 3,690 shares in the last quarter. Price T Rowe Associates Inc. MD acquired a new stake in shares of Hyperion DeFi during the 4th quarter valued at $73,000. State Street Corp acquired a new stake in shares of Hyperion DeFi during the 4th quarter valued at $92,000. Jane Street Group LLC bought a new stake in Hyperion DeFi during the 4th quarter worth $493,000. Finally, Renaissance Technologies LLC bought a new stake in Hyperion DeFi during the 4th quarter worth $663,000. 25.84% of the stock is currently owned by institutional investors and hedge funds.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.